4Filed Aug 18, 8:00 PM ET

MapLight (MPLT) CMO Erin Foff Receives 67,600-Share Award

$MPLT · MapLight Therapeutics, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

MapLight (MPLT) CMO Erin Foff Receives 67,600-Share Award

What Happened
Erin Foff (Chief Medical Officer) was granted a total of 67,600 stock-based awards on 2026-08-17: 13,360 restricted stock units (RSUs) and 54,240 derivative/contingent awards. Both grants were reported as acquisitions at $0.00 per share (no cash exchanged) — these are compensation awards, not open-market purchases or sales.

Key Details

  • Transaction date: 2026-08-17; Form 4 filed 2026-08-19 (appears timely).
  • Grants: 13,360 RSUs @ $0.00 (F1/F2); 54,240 derivative award units @ $0.00 (F3). Total = 67,600 shares underlying awards.
  • Reported value on Form 4: $0 (grant price $0.00).
  • Shares owned after transaction: Not disclosed in this filing.
  • Footnotes / vesting:
    • F1: The 13,360 RSUs — 1/4 vest on July 1, 2027, then 1/16 vest each Oct 1, Jan 1, Apr 1 and Jul 1 thereafter, contingent on continued service.
    • F2: Each RSU converts to one share of voting common stock when vested.
    • F3: The 54,240 derivative awards: 1/4 of the total vests on July 1, 2027, then 1/48 of the total vests each month thereafter, contingent on continued service.
  • Transaction code: A = Award/Grant.

Context
These awards are compensation grants that vest over time; they do not represent immediate ownership of tradable shares until vesting/conversion. Such grants are routine for executives and are not sales (which often indicate liquidity), nor immediate purchases (which can be interpreted as strong insider conviction).